US Stock MarketDetailed Quotes

AGEN Agenus

Watchlist
  • 4.220
  • +0.070+1.69%
Close Nov 6 16:00 ET
  • 4.150
  • -0.070-1.66%
Post 17:31 ET
91.03MMarket Cap-378P/E (TTM)

About Agenus Company

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Company Profile

SymbolAGEN
Company NameAgenus
Listing DateFeb 4, 2000
Issue Price18.00
Founded1994
CEODr. Garo H. Armen, PhD
MarketNASDAQ
Employees389
Fiscal Year Ends12-31
Address3 Forbes Road
CityLexington
ProvinceMassachusetts
CountryUnited States of America
Zip Code02421-7305
Phone1-781-674-4400
Websitehttp://www.agenusbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Garo H. Armen, PhD
  • Chairman of the Board and Chief Executive Officer
  • 5.86M
  • Steven J. O'Day
  • Chief Medical Officer
  • 1.44M
  • Christine M. Klaskin
  • Vice President, Finance, Principal Financial Officer and Principal Accounting Officer
  • 712.75K
  • Thomas L. Harrison
  • Director
  • --
  • Dr. Jennifer S. Buell, PhD
  • Director
  • --
  • Timothy R. Wright
  • Lead Independent Director
  • 385.50K
  • Brian J. Corvese
  • Independent Director
  • 888.14K
  • Susan B. Hirsch
  • Independent Director
  • 242.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data